These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2658349)

  • 21. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States.
    Schootman M; Jeffe D; Reschke A; Aft R
    Breast Cancer Res Treat; 2004 Jun; 85(3):219-22. PubMed ID: 15111759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-related differences in patients with nonpalpable breast carcinomas.
    Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
    Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival advantage differences by age. Evaluation of the extended follow-up of the Breast Cancer Detection Demonstration Project.
    Byrne C; Smart CR; Chu KC; Hartmann WH
    Cancer; 1994 Jul; 74(1 Suppl):301-10. PubMed ID: 8004601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggressiveness of breast cancers found with and without screening.
    Klemi PJ; Joensuu H; Toikkanen S; Tuominen J; Räsänen O; Tyrkkö J; Parvinen I
    BMJ; 1992 Feb; 304(6825):467-9. PubMed ID: 1547414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening.
    Kricker A; Farac K; Smith D; Sweeny A; McCredie M; Armstrong BK
    Int J Cancer; 1999 Jun; 81(6):877-80. PubMed ID: 10362133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
    Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
    J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs.
    Tabár L; Yen AM; Wu WY; Chen SL; Chiu SY; Fann JC; Ku MM; Smith RA; Duffy SW; Chen TH
    Breast J; 2015; 21(1):13-20. PubMed ID: 25413699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?
    Paci E; Warwick J; Falini P; Duffy SW
    J Med Screen; 2004; 11(1):23-7. PubMed ID: 15006110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening breast MR imaging in women with a history of lobular carcinoma in situ.
    Sung JS; Malak SF; Bajaj P; Alis R; Dershaw DD; Morris EA
    Radiology; 2011 Nov; 261(2):414-20. PubMed ID: 21900617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor size distribution of invasive breast cancers and the sensitivity of screening methods in the Canadian National Breast Screening Study.
    Shaevitch D; Taghipour S; Miller AB; Montgomery N; Harvey B
    J Cancer Res Ther; 2017; 13(3):562-569. PubMed ID: 28862227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004.
    Paajanen H; Kyhälä L; Varjo R; Rantala S
    Am Surg; 2006 Feb; 72(2):167-71. PubMed ID: 16536250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
    Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
    J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology and growth rate of interval breast carcinoma. Characterization of different subgroups.
    Brekelmans CT; van Gorp JM; Peeters PH; Collette HJ
    Cancer; 1996 Sep; 78(6):1220-8. PubMed ID: 8826943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natural history of human cancer and prognostic factors. The example of breast cancer].
    Tubiana M; Koscielny S
    Bull Cancer; 1987; 74(1):43-57. PubMed ID: 3567387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.